Christopher S. Lynch is Director at TENET HEALTHCARE CORP (THC). They have made 6 open-market trades across 2 companies since 2012, most recently 2026-07-27.
CIK 0001452627
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2012, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| THC | 9,568 | $2.6M |
| CRBG | 34,962 | $1.2M |
| AIG | 3,155 | $255K |
| Total | $4.0M |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| THC | SELL | 2026-07-27 | 2026-07-28 | $243.44 | $934K | +1.5% | +3.6% | — |
| THC | SELL | 2025-08-28 | 2025-08-29 | $183.44 | $1K | +5.3% | +9.6% | +18.1% |
| THC | SELL | 2025-08-19 | 2025-08-21 | $176.39 | $1.4M | +5.0% | +9.0% | +9.1% |
| THC | SELL | 2024-05-30 | 2024-06-03 | $133.83 | $2.9M | +5.2% | +2.5% | +21.9% |
| THC | SELL | 2024-02-15 | 2024-02-16 | $89.60 | $1.4M | +3.4% | +11.6% | +42.3% |
| AIG | BUY | 2012-05-08 | 2012-05-10 | $31.68 | $100K | -6.4% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.